BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1090 related articles for article (PubMed ID: 28655327)

  • 1. Advances in the delivery of RNA therapeutics: from concept to clinical reality.
    Kaczmarek JC; Kowalski PS; Anderson DG
    Genome Med; 2017 Jun; 9(1):60. PubMed ID: 28655327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unresolved Issues in RNA Therapeutics in Vascular Diseases With a Focus on Aneurysm Disease.
    Schellinger IN; Dannert AR; Mattern K; Raaz U; Tsao PS
    Front Cardiovasc Med; 2021; 8():571076. PubMed ID: 33937351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Therapeutics: How Far Have We Gone?
    Coutinho MF; Matos L; Santos JI; Alves S
    Adv Exp Med Biol; 2019; 1157():133-177. PubMed ID: 31342441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic acid therapeutics in neurodevelopmental disease.
    Winkelsas AM; Fischbeck KH
    Curr Opin Genet Dev; 2020 Dec; 65():112-116. PubMed ID: 32623324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-targeted therapeutics in cancer clinical trials: Current status and future directions.
    Barata P; Sood AK; Hong DS
    Cancer Treat Rev; 2016 Nov; 50():35-47. PubMed ID: 27612280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Delivery in Lipid Research and Therapies.
    De Giorgi M; Lagor WR
    Methodist Debakey Cardiovasc J; 2019; 15(1):62-69. PubMed ID: 31049151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress on RNA-based therapeutics for genetic diseases.
    Luo T; Huo C; Zhou T; Xie S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):406-416. PubMed ID: 37643975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent progress and prospect in oligonucleotide therapeutics].
    Yoshioka K; Kuwahara H; Nishina K; Nagata T; Yokota T
    Nihon Rinsho; 2015 Jun; 73(6):1057-65. PubMed ID: 26065142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frameworks for transformational breakthroughs in RNA-based medicines.
    Androsavich JR
    Nat Rev Drug Discov; 2024 Jun; 23(6):421-444. PubMed ID: 38740953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The infinite possibilities of RNA therapeutics.
    Mollocana-Lara EC; Ni M; Agathos SN; Gonzales-Zubiate FA
    J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34463324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA therapeutics: updates and future potential.
    Zhang C; Zhang B
    Sci China Life Sci; 2023 Jan; 66(1):12-30. PubMed ID: 36100838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense technology: an emerging platform for cardiovascular disease therapeutics.
    Lee RG; Crosby J; Baker BF; Graham MJ; Crooke RM
    J Cardiovasc Transl Res; 2013 Dec; 6(6):969-80. PubMed ID: 23856914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA therapeutics in ophthalmology - translation to clinical trials.
    Gupta A; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
    Exp Eye Res; 2021 Apr; 205():108482. PubMed ID: 33548256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oligonucleotide therapeutics - an emerging novel class of compounds].
    Wacheck V
    Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA Therapeutics in Oncology: Advances, Challenges, and Future Directions.
    MacLeod AR; Crooke ST
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S43-S59. PubMed ID: 28921648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing disease genes in the laboratory and the clinic.
    Watts JK; Corey DR
    J Pathol; 2012 Jan; 226(2):365-79. PubMed ID: 22069063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic applications of CRISPR RNA-guided genome editing.
    Koo T; Kim JS
    Brief Funct Genomics; 2017 Jan; 16(1):38-45. PubMed ID: 27562951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-Specific Delivery of Oligonucleotides.
    Xia X; Pollock N; Zhou J; Rossi J
    Methods Mol Biol; 2019; 2036():17-50. PubMed ID: 31410789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.